“My readings are only a bit up — do I really need to be on pills for the rest of my life at 58?”

A borderline blood-pressure decision is made in stages. First CONFIRM the diagnosis — do not treat a single clinic reading; verify with ambulatory (ABPM) or home (HBPM) monitoring, where (NICE NG136) stage 1 hypertension is a clinic BP of 140/90–159/99 with an ABPM/HBPM daytime average of 135/85–149/94, and stage 2 is clinic ≥160/100 and ABPM/HBPM ≥150/95 — which also excludes white-coat effect. Then recognise that in STAGE 1 the decision to start drug treatment is RISK-BASED, not number-based: NICE NG136 advises discussing starting antihypertensives with people under 80 with stage 1 hypertension who have target-organ damage, established cardiovascular disease, renal disease, diabetes, or a 10-year cardiovascular (QRISK3) risk ≥10%, and considering treatment in those under 60 with stage 1 even if the 10-year risk is <10% (10-year scores underestimate lifetime risk); first line at 55 or over is a calcium-channel blocker. So estimate QRISK and assess for target-organ damage (urine ACR and haematuria, renal function/HbA1c/lipids, ECG for LVH, fundi — the examination and ECG face to face), considering secondary causes if features suggest — the number alone does not decide it. Emphasise LIFESTYLE for everyone whether or not drugs start (weight, salt, alcohol, exercise, diet, smoking, caffeine), as it meaningfully lowers BP and CVD risk and can reduce or avoid medication. Reframe "tablets forever" honestly: treatment is reviewed at least annually and a dose reduction can be discussed if lifestyle lowers BP (clinical practice rather than an NG136 recommendation), though for many it is long term, and where warranted, explain the genuine absolute benefits (stroke, MI, renal and eye protection) the patient can weigh. The hidden agenda is feeling well, dislike of medicalisation and wanting control — respect autonomy, confirm the diagnosis, individualise with QRISK/organ-damage, offer lifestyle, and make a genuine SHARED decision, neither dismissing the raised BP nor railroading onto lifelong tablets, with monitoring and review whichever path is chosen.